Recently, N-myc downstream-regulated gene 1 protein (NDRG1)13 and Activated leukocyte cell adhesion molecule (ALCAM, CD166)14 have been identified as novel tumour markers for clinical diagnosis of HCC. The gene discussed is ALCAM; the disease is hepatocellular carcinoma.